Dipeptidyl peptidase-IV inhibitors

Details for Australian Patent Application No. 2006239929 (hide)

Owner Alantos Pharmaceuticals Holding, Inc.

Inventors Steeneck, Christoph; Essers, Michael; Richter, Frank; Taveras, Arthur; Feuerstein, Tim; Schneider, Matthias; Nolte, Bert; Kroth, Heiko; Hochguertel, Matthias; Frickel, Fritz-Frieder; Boer, Jurgen

Agent Allens Arthur Robinson

Pub. Number AU-B-2006239929

PCT Pub. Number WO2006/116157

Priority 60/674,151 22.04.05 US

Filing date 21 April 2006

Wipo publication date 2 November 2006

Acceptance publication date 3 November 2011

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/116157 Priority application(s): WO2006/116157

3 November 2011 Application Accepted

  Published as AU-B-2006239929

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239930-Benzodioxane and benzodioxolane derivatives and uses thereof

2006239928-Toxin peptide therapeutic agents